Genenta Science S.p.A GNTA
NASDAQ GNTA
$1.26 +0.07 (+5.88%)
At close: Aug 21, 2026 · 4:00 PM EDT

Genenta Science S.p.A (GNTA) Accumulated Expenses (2020 - 2025)

Genenta Science S.p.A (GNTA) posted Accumulated Expenses of $90995.6 for Q4 2025, down 65.16% sequentially from $261156.7 in Q2 2025, and down 91.74% YoY from $1.1 million in Q4 2024.

Genenta Science S.p.A (GNTA) Accumulated Expenses (2020 - 2025) Analysis & Trends

Genenta Science S.p.A has reported Accumulated Expenses for 6 years, with the latest figure at $90995.6 in Q4 2025.

  • Quarterly Accumulated Expenses fell 91.74% year-over-year to $90995.6 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $90995.6 (down 91.74% YoY) and the FY2025 annual result came in at $90995.6, down 91.74% from the prior year.
  • Accumulated Expenses fell to $90995.6 in Q4 2025 per GNTA's latest filing, from $261156.7 in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $1.1 million in Q4 2024 and troughed at $90995.6 in Q4 2025.
  • A 5-year average of $542364.4 and a median of $499112.2 in 2022 frame the typical range for Accumulated Expenses.
  • The sharpest annual moves came in 2022 and 2025: Accumulated Expenses soared 230.18% in 2022, then slumped 91.74% in 2025.
  • Over 5 years, Accumulated Expenses stood at $151165.5 in 2021, then jumped by 230.18% to $499112.2 in 2022, then soared by 85.73% to $927006.2 in 2023, then climbed by 18.89% to $1.1 million in 2024, then plunged by 91.74% to $90995.6 in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $90995.6, $261156.7, and $1.1 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Genenta Science S.p.A 25.03 Mn -34.07 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 90,995.61
Jun 30, 2025 261,156.68
Dec 31, 2024 1.10 Mn
Jun 30, 2024 752,602.27
Dec 31, 2023 927,006.15
Jun 30, 2023 688,615.10
Dec 31, 2022 499,112.15
Jun 30, 2022 408,535.46
Dec 31, 2021 151,165.47
Dec 31, 2020 436,341.12